ADICON (HKG:9860) has resolved to buy back up to 36,287,165 shares in the open market at a maximum price of HK$9.69 apiece under its repurchase mandate, a Thursday bourse filing said.
The shares represent around 5% of the clinical laboratory service provider's issued shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.